Fig. 2.

Persistent Viremia is often followed by LLV. a Follow-up events (no events, transient HIV-1 RNA blips, showing up with episodes of low-level viremia) of patients who received a first-line therapy and who reached pVL <50 RNA copies/ml were depicted (left). Sub-analysis of patients reaching pVL <50 who had low drug levels as well drug-resistant viruses (middle) and those who had not (right). b Total HIV-1 DNA, integrated proviral DNA, and non-integrated viral DNA (2-LTR circles) were determined using DNA isolated from PBMCs collected at time point of genotyping. The lines indicate mean values